U.S. Stem Cell
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. U.S. Stem Cell's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 59% to $82,049. The net income raised on -$3,305,425 and profit margin reached -4029%. Total operating expenses were $1,778,766.

Profit Margin

U.S. Stem Cell, Inc. (OTC:USRM): Profit margin
2013 96.08K -3.14M -3271.33%
2014 2.05M -2.25M -109.62%
2015 2.19M -1.64M -74.93%
2016 3.08M -2.07M -67.15%
2017 5.52M -3.48M -63.06%
2018 6.70M -2.16M -32.24%
2019 3.07M -5.03M -163.89%
2020 277.08K -3.37M -1219.42%
2021 200.74K -4.28M -2135.78%
2022 82.04K -3.30M -4028.6%

USRM Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
82.04K200.74K277.08K3.07M6.70M5.52M3.08M2.19M2.05M96.08K
Cost of revenue
23.76K52.03K64.11K1.33M2.11M1.88M972.00K972.95K844.94K30.83K
Gross profit
58.28K148.71K212.97K1.73M4.59M3.63M2.11M1.21M1.21M65.25K
Operating exp.
Research and development
0002635.43K6.64K91910K66.42K626.98K
Selling and marketing
0000000000
Total operating expenses
1.77M2.28M2.61M5.15M5.68M4.43M3.27M3.82M4.74M2.89M
Operating income
-1.72M-2.13M-2.40M-3.41M-1.09M-804.68K-1.15M-2.60M-3.52M-2.83M
Other income (expenses), net
-1.13M-1.15M-490.25K-418.48K382.28K-2.67M274.81K963.85K1.27M1.12M
Income before tax
-2.85M-3.28M-2.89M-3.83M-2.16M-3.48M-2.07M-1.64M-2.25M-3.14M
Income tax expense
447.48K1.00M488.36K1.19M1.06M2.67M910.82K-963.85K-1.27M311.50K
Net income
-3.30M-4.28M-3.37M-5.03M-2.16M-3.48M-2.07M-1.64M-2.25M-3.14M
Earnings per share
Basic EPS
-0.00-0.00-0.00-0.01-0.00-0.01-0.08-1.8-4.61-12.48
Diluted EPS
-0.00-0.00-0.00-0.01-0.00-0.01-0.08-1.8-4.61-12.48
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source